ACM
ALNA

Altium Capital Management’s Allena Pharmaceuticals ALNA Stock Holding History

Altium Capital Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,067,886
Closed -$963K – 171
2021
Q3 		$963K Buy
+1,067,886
New +$1.05M 0.25% 101

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Altium Capital Management's ALNA Position: Q4 2021 in Review

Altium Capital Management sold out of Allena Pharmaceuticals (ALNA) in Q4 2021, closing a stake of 1,067,886 shares — an estimated $963K sold.

Altium Capital Management first reported a position in ALNA in Q3 2021 and held it in 1 quarter. The position peaked at $963K in Q3 2021. 30 funds tracked by Wall St. Rank hold ALNA as of Q4 2021.

  • Altium Capital Management reported no remaining Allena Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Altium Capital Management sold 1,067,886 Allena Pharmaceuticals shares in Q4 2021, an estimated $963K.
  • Altium Capital Management first reported a position in Allena Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Altium Capital Management's Allena Pharmaceuticals position peaked at $963K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2021.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.